Jon S[Author] - Search Results

Year	Number of Results
2001	3
2002	1
2003	3
2004	5
2005	3
2006	6
2007	11
2008	6
2009	9
2010	10
2011	11
2012	10
2013	7
2014	13
2015	6
2016	13
2017	17
2018	13
2019	7
2020	14
2021	10
2022	8
2023	5
2024	3

1

Hyaluronic acid-bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis.

Lee Y, Sugihara K, Gillilland MG 3rd, Jon S, Kamada N, Moon JJ. Lee Y, et al. Among authors: jon s. Nat Mater. 2020 Jan;19(1):118-126. doi: 10.1038/s41563-019-0462-9. Epub 2019 Aug 19. Nat Mater. 2020. PMID: 31427744 Free PMC article.

2

Photomedicine based on heme-derived compounds.

Keum H, Yoo D, Jon S. Keum H, et al. Among authors: jon s. Adv Drug Deliv Rev. 2022 Mar;182:114134. doi: 10.1016/j.addr.2022.114134. Epub 2022 Feb 3. Adv Drug Deliv Rev. 2022. PMID: 35122881 Review.

3

Magnetic nanoparticle-based theranostics.

Xie J, Jon S. Xie J, et al. Among authors: jon s. Theranostics. 2012;2(1):122-4. doi: 10.7150/thno.4051. Epub 2012 Jan 16. Theranostics. 2012. PMID: 22287992 Free PMC article.

4

Nanoparticles derived from naturally occurring metal chelators for theranostic applications.

Jung W, Lee DY, Moon E, Jon S. Jung W, et al. Among authors: jon s. Adv Drug Deliv Rev. 2022 Dec;191:114620. doi: 10.1016/j.addr.2022.114620. Epub 2022 Nov 13. Adv Drug Deliv Rev. 2022. PMID: 36379406 Review.

5

Bilirubin Nanomedicine Rescues Intestinal Barrier Destruction and Restores Mucosal Immunity in Colitis.

Rahman AT, Shin J, Whang CH, Jung W, Yoo D, Seo C, Cho BK, Jon S. Rahman AT, et al. Among authors: jon s. ACS Nano. 2023 Jun 13;17(11):10996-11013. doi: 10.1021/acsnano.3c03252. Epub 2023 May 25. ACS Nano. 2023. PMID: 37227087

6

Nanovaccine Displaying Immunodominant T Cell Epitopes of Fibroblast Activation Protein Is Effective Against Desmoplastic Tumors.

Shin H, Kim Y, Jon S. Shin H, et al. Among authors: jon s. ACS Nano. 2023 Jun 13;17(11):10337-10352. doi: 10.1021/acsnano.3c00764. Epub 2023 May 15. ACS Nano. 2023. PMID: 37184372

7

Impact of media compositions and culture systems on the immunophenotypes of patient-derived breast cancer cells.

Ryu S, Yoon SH, Song J, Choi Y, Lee S, Baek M, Lee HB, Jeon SY, Jon S, Lee D, Kim HS, Han W. Ryu S, et al. Among authors: jon s. BMC Cancer. 2023 Sep 6;23(1):831. doi: 10.1186/s12885-023-11185-7. BMC Cancer. 2023. PMID: 37670250 Free PMC article.

8

Bioengineered bacterial outer membrane vesicles: what is their potential in cancer therapy?

Gujrati VB, Jon S. Gujrati VB, et al. Among authors: jon s. Nanomedicine (Lond). 2014 May;9(7):933-5. doi: 10.2217/nnm.14.56. Nanomedicine (Lond). 2014. PMID: 24978458 No abstract available.

9

Multistimuli-Responsive Bilirubin Nanoparticles for Anticancer Therapy.

Lee Y, Lee S, Lee DY, Yu B, Miao W, Jon S. Lee Y, et al. Among authors: jon s. Angew Chem Int Ed Engl. 2016 Aug 26;55(36):10676-80. doi: 10.1002/anie.201604858. Epub 2016 Aug 3. Angew Chem Int Ed Engl. 2016. PMID: 27485478

10

Purification of Therapeutic Antibodies Using the Ca²⁺-Dependent Phase-Transition Properties of Calsequestrin.

Park H, Jeon H, Cha HJ, Bang J, Song Y, Choi M, Sung D, Choi WI, Lee JH, Woo JS, Jon S, Kim S. Park H, et al. Among authors: jon s. Anal Chem. 2022 Apr 19;94(15):5875-5882. doi: 10.1021/acs.analchem.2c00026. Epub 2022 Apr 7. Anal Chem. 2022. PMID: 35389207

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

177 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

177 results

Results by year